Manuel
Valladares Ayerbes
Universidade da Coruña
La Coruña, EspañaPublicacións en colaboración con investigadores/as de Universidade da Coruña (40)
2021
-
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231
-
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study
ESMO open, Vol. 6, Núm. 2, pp. 100062
2019
-
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients
British Journal of Cancer, Vol. 121, Núm. 5, pp. 378-383
2018
-
A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer
Clinical Colorectal Cancer, Vol. 17, Núm. 2, pp. e323-e329
-
Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): A pharmacogenetic-based randomized phase II trial
Annals of Oncology, Vol. 29, Núm. 2, pp. 439-444
-
Hakai overexpression effectively induces tumour progression and metastasis in vivo
Scientific Reports, Vol. 8, Núm. 1
2017
-
First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)
European Journal of Cancer, Vol. 81, pp. 191-202
-
Proteomic Analysis of the E3 Ubiquitin-Ligase Hakai Highlights a Role in Plasticity of the Cytoskeleton Dynamics and in the Proteasome System
Journal of Proteome Research, Vol. 16, Núm. 8, pp. 2773-2788
2015
-
Circulating miR-200c and miR-141 and outcomes in patients with breast cancer
BMC Cancer, Vol. 15, Núm. 1
-
Current controversies in the management of metastatic colorectal cancer
Cancer Chemotherapy and Pharmacology, Vol. 76, Núm. 4, pp. 659-677
2014
-
Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer
Future Oncology, Vol. 10, Núm. 7, pp. 1187-1202
2012
-
Circulating MicroRNAs: Molecular microsensors in gastrointestinal cancer
Sensors (Switzerland), Vol. 12, Núm. 7, pp. 9349-9362
-
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
Journal of Translational Medicine, Vol. 10, Núm. 1
-
Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer
International Journal of Molecular Sciences, Vol. 13, Núm. 4, pp. 4367-4387
-
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: Clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD group study
Oncologist, Vol. 17, Núm. 3, pp. 339-345
-
Multiple biomarker tissue arrays: A computational approach to identifying protein-protein interactions in the EGFR/ERK signalling pathway
Journal of Molecular Signaling, Vol. 7
-
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: Relationship between skin rash and survival (Pantar study)
Annals of Oncology, Vol. 23, Núm. 7, pp. 1919-1925
-
Searching for Hif1-α interacting proteins in renal cell carcinoma
Clinical and Translational Oncology, Vol. 14, Núm. 9, pp. 698-708
-
State of the art in Silico tools for the study of signaling pathways in cancer
International Journal of Molecular Sciences, Vol. 13, Núm. 6, pp. 6561-6581
2011
-
A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues
Proteomics, Vol. 11, Núm. 12, pp. 2555-2559